• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PRINGY JUVEDERM VOLUX XC 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PRINGY JUVEDERM VOLUX XC 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 20073770
Medical Device Problem Codes Off-Label Use (1494); Improper or Incorrect Procedure or Method (2017)
Health Effect - Clinical Code Obstruction/Occlusion (2422)
Date of Event 10/19/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.This is a known potential adverse event addressed in the product labeling.
 
Event or Problem Description
Healthcare professional reported injecting a patient with juvéderm® volux¿ xc in the temples.Patient experienced a vascular occlusion in the temples 48 hours post injection.Hcp noted they are following "vascular occlusion protocol" for treatment.Symptoms are ongoing.
 
Additional Manufacturer Narrative
Information about this case was previous submitted in mfr report #3005113652-2025-00966.All information will be consolidated into this mdr.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.Additional, changed, and/or corrected data: a2, a3, b3, b5, b6, b7, section c, d4, d6a, h4, h6, h8.
 
Event or Problem Description
Additionally, the healthcare professional reported that the patient was also injected in the hairline.The next day, the patient reported "discomfort, bruise, and pressure" and the patient was advised to take aspirin 81 mg and a warm compress.The next day, the patient awoke with "blisters/pimples and was treated with doxycycline 100 mg and viagra 50 mg.The event resolved a month later.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUX XC 2 X 1ML
Common Device Name
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
PRINGY
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
PRINGY
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
terry ingram
2525 dupont drive
irvine, CA 92612
8479366324
MDR Report Key23441708
Report Number3005113652-2025-00975
Device Sequence Number8552298
Product Code LMH
UDI-Device Identifier10840228300073
UDI-Public(01)10840228300073(10)1002350432(11)240821(17)260721
Combination Product (Y/N)Y
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
P110033
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 12/18/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/21/2026
Device Catalogue Number20073770
Device Lot Number1002350432
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 10/20/2025
Supplement Date Received by Manufacturer12/17/2025
Initial Report FDA Received Date10/31/2025
Supplement Report FDA Received Date12/18/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/21/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age42 YR
Patient SexFemale
Patient RaceWhite
-
-